{"organizations": [], "uuid": "a300447807109a148f8b7a074d358f3a62348ca7", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-tonix-pharmaceuticals-receives-ind/brief-tonix-pharmaceuticals-receives-ind-clearance-by-u-s-fda-for-tnx-102-sl-idUSFWN1S806X", "country": "US", "domain_rank": 408, "title": "BRIEF-Tonix Pharmaceuticals Receives IND Clearance By U.S. FDA For TNX-102 SL", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-01T14:21:00.000+03:00", "replies_count": 0, "uuid": "a300447807109a148f8b7a074d358f3a62348ca7"}, "author": "", "url": "https://www.reuters.com/article/brief-tonix-pharmaceuticals-receives-ind/brief-tonix-pharmaceuticals-receives-ind-clearance-by-u-s-fda-for-tnx-102-sl-idUSFWN1S806X", "ord_in_thread": 0, "title": "BRIEF-Tonix Pharmaceuticals Receives IND Clearance By U.S. FDA For TNX-102 SL", "locations": [], "entities": {"persons": [{"name": "alzheimer", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "tnx-102 sl reuters staff", "sentiment": "none"}, {"name": "u.s. fda", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "tonix pharmaceuticals holding corp", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 1, 2018 / 11:21 AM / Updated 13 minutes ago BRIEF-Tonix Pharmaceuticals Receives IND Clearance By U.S. FDA For TNX-102 SL Reuters Staff 1 Min Read\nMay 1 (Reuters) - Tonix Pharmaceuticals Holding Corp :\n* TONIX PHARMACEUTICALS RECEIVES IND CLEARANCE BY U.S. FDA FOR TNX-102 SL IN AGITATION IN ALZHEIMERâ€™S DISEASE Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-05-01T14:21:00.000+03:00", "crawled": "2018-05-01T14:41:49.009+03:00", "highlightTitle": ""}